Exenatide is a 39-amino acid peptide originally isolated from the venom of the Gila monster (Heloderma suspectum). It is a synthetic analog of exendin-4, a…

The original GLP-1 receptor agonist that opened the door for semaglutide and tirzepatide.

Semaglutide is one of the most evidence-supported peptide therapies in medicine, approved for type 2 diabetes and obesity.

A triple agonist (GLP-1 / GIP / glucagon) with weight-loss effect sizes that exceed even tirzepatide in Phase 2.

Tirzepatide is the most effective approved weight-loss therapy currently in clinical practice.

? Investigational